IGF-1 LR3 Research Reference

IGF-1 LR3 is a long-acting IGF-1 analog researched for IGF-1 receptor signaling, amino-acid uptake, nutrient partitioning, and tissue-growth pathway activity. Glucose monitoring and conservative exposure are central. IGF-1 LR3 is catalogued in the Growth Hormone Axis group of this reference and is studied in laboratory and in-vitro models only.

Reference half-life for IGF-1 LR3: extended vs native IGF-1; context dependent. LR3 modification extends functional exposure compared with native IGF-1. Human research-use PK depends on formulation and route; glucose-aware interpretation is required. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.

Use solvent appropriate to formulation. Refrigerate after reconstitution, protect from heat/light, and avoid repeated temperature cycling. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.

The reference reconstitution for the 1 mg vial is 1 mL AA water preferred for stability; dilute only if protocol requires, which gives a concentration of about 1 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.

No. The research-grade IGF-1 LR3 described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.